Transgene SA

Transgene SA

0.75
USD
-0.05
(-6.85%)
230.63MMarket Cap
Mar 31Next Earn

Total Valuation

USD

As of June 30, 2026, TRANSGENE S.A. carries a market capitalization of 230.63M, placing it among publicly traded companies globally. Its enterprise value stands at 124.56M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap230.63M
Enterprise Value124.56M

Important Dates

TRANSGENE S.A.'s next confirmed earnings release is scheduled for March 31, 2027.

Earnings Date3/31/2027

Share Statistics

As of June 30, 2026, TRANSGENE S.A. has 278.26M shares outstanding.

Shares Outstanding278.26M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio1.85
P/TBV Ratio1.85

Financial Position

As of June 30, 2026, TRANSGENE S.A. maintains a current ratio of 9.40, meaning it holds 9.4x the short-term assets needed to cover near-term liabilities.

Current Ratio9.40
Quick Ratio8.68

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count156.00

Stock Price Statistics

USD

As of the close on October 26, 2026, TRANSGENE S.A.'s stock has gained approximately 6.46% over the past 52 weeks.

52-Week Price Change6.46%
50-Day Moving Average2.07

Balance Sheet

USD

These figures are as of June 30, 2026. Total book value stands at 124.75M, with working capital of 102.68M providing operational flexibility.

Cash & Cash Equivalents106.07M
Net Debt-4.85M
Equity (Book Value)124.75M
Book Value Per Share0.45
Working Capital102.68M

Stock Splits

TRANSGENE S.A.'s most recent stock split took place on June 18, 2019 with a 39:40 split ratio.

Last Split Date6/18/2019
Split Ratio39:40